Literature DB >> 21612259

Toward therapeutic delivery with layer-by-layer engineered particles.

Yan Yan1, Georgina K Such, Angus P R Johnston, Hannah Lomas, Frank Caruso.   

Abstract

Layer-by-layer (LbL)-engineered particles have recently emerged as a promising class of materials for applications in biomedicine, with studies progressing from in vitro to in vivo. The versatility of LbL assembly coupled with particle templating has led to engineered particles with specific properties (e.g., stimuli-responsive, high cargo encapsulation efficiency, targeting), thus offering new opportunities in targeted and triggered therapeutic release. This Perspective highlights an important development by Poon et al. on tumor targeting in vivo using LbL-engineered nanoparticles containing a pH-responsive poly(ethylene glycol) (PEG) surface layer. Further, we summarize recent progress in the application of LbL particles in the fields of drug, gene, and vaccine delivery and cancer imaging. Finally, we explore future directions in this field, focusing on the biological processing of LbL-assembled particles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21612259     DOI: 10.1021/nn201793f

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  10 in total

Review 1.  Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.

Authors:  Jing Li; Yan Wang; Yu Zhu; David Oupický
Journal:  J Control Release       Date:  2013-04-25       Impact factor: 9.776

2.  Graphene multilayers as gates for multi-week sequential release of proteins from surfaces.

Authors:  Jinkee Hong; Nisarg J Shah; Adam C Drake; Peter C DeMuth; Jong Bum Lee; Jianzhu Chen; Paula T Hammond
Journal:  ACS Nano       Date:  2011-12-29       Impact factor: 15.881

3.  Biocompatible, photo-responsive layer-by-layer polymer nanocapsules with an oil core: in vitro and in vivo study.

Authors:  Chiara Di Cicco; Raffaele Vecchione; Vincenzo Quagliariello; Alice Busato; Immacolata Tufano; Emiliano Bedini; Marco Gerosa; Andrea Sbarbati; Federico Boschi; Pasquina Marzola; Nicola Maurea; Paolo A Netti
Journal:  J R Soc Interface       Date:  2022-02-23       Impact factor: 4.118

4.  Functional block copolymer nanoparticles: toward the next generation of delivery vehicles.

Authors:  Maxwell J Robb; Luke A Connal; Bongjae F Lee; Nathaniel A Lynd; Craig J Hawker
Journal:  Polym Chem       Date:  2012       Impact factor: 5.582

5.  Multilayer thin film coatings capable of extended programmable drug release: application to human mesenchymal stem cell differentiation.

Authors:  Jinkee Hong; Luis M Alvarez; Nisarg J Shah; Linda G Griffith; Byeong-Su Kim; Kookheon Char; Paula T Hammond
Journal:  Drug Deliv Transl Res       Date:  2012-10       Impact factor: 4.617

6.  Multimodal delivery of irinotecan from microparticles with two distinct compartments.

Authors:  Sahar Rahmani; Tae-Hong Park; Acacia Frances Dishman; Joerg Lahann
Journal:  J Control Release       Date:  2013-08-23       Impact factor: 9.776

Review 7.  Developments in the use of nanocapsules in oncology.

Authors:  V Yurgel; T Collares; F Seixas
Journal:  Braz J Med Biol Res       Date:  2013-05-28       Impact factor: 2.590

8.  Surface Engineering for Mechanical Enhancement of Cell Sheet by Nano-Coatings.

Authors:  Miso Yang; Eunah Kang; Jong Wook Shin; Jinkee Hong
Journal:  Sci Rep       Date:  2017-06-30       Impact factor: 4.379

9.  Layer-by-layer biofunctionalization of nanostructured porous silicon for high-sensitivity and high-selectivity label-free affinity biosensing.

Authors:  Stefano Mariani; Valentina Robbiano; Lucanos M Strambini; Aline Debrassi; Gabriela Egri; Lars Dähne; Giuseppe Barillaro
Journal:  Nat Commun       Date:  2018-12-10       Impact factor: 14.919

10.  Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy in vivo.

Authors:  Wanfu Men; Peiyao Zhu; Siyuan Dong; Wenke Liu; Kun Zhou; Yu Bai; Xiangli Liu; Shulei Gong; Shuguang Zhang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.